Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LMNL

Liminal BioSciences (LMNL) Stock Price, News & Analysis

Liminal BioSciences logo

About Liminal BioSciences Stock (NASDAQ:LMNL)

Advanced Chart

Key Stats

Today's Range
$8.50
$8.50
50-Day Range
$8.38
$8.50
52-Week Range
$3.10
$8.50
Volume
N/A
Average Volume
63,470 shs
Market Capitalization
$26.35 million
P/E Ratio
29.31
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LMNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liminal BioSciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LMNL Stock News Headlines

Buffett, Gates and Bezos Dumping Stocks
The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.tc pixel
See More Headlines

LMNL Stock Analysis - Frequently Asked Questions

Liminal BioSciences Inc. (NASDAQ:LMNL) released its quarterly earnings data on Monday, November, 15th. The company reported $27.40 EPS for the quarter, beating the consensus estimate of ($2.80) by $30.20. The business earned $0.14 million during the quarter, compared to the consensus estimate of $0.02 million. Liminal BioSciences had a net margin of 248.35% and a negative trailing twelve-month return on equity of 88.44%.

Liminal BioSciences shares reverse split before market open on Wednesday, February 1st 2023.The 1-10 reverse split was announced on Wednesday, February 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liminal BioSciences investors own include Corbus Pharmaceuticals (CRBP), Bionano Genomics (BNGO), HubSpot (HUBS), iBio (IBIO), Dynavax Technologies (DVAX), Diamondback Energy (FANG) and NIO (NIO).

Company Calendar

Last Earnings
11/15/2021
Today
9/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LMNL
CIK
1351172
Employees
251
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.29
Trailing P/E Ratio
29.31
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$380 thousand
Net Margins
248.35%
Pretax Margin
-5,729.40%
Return on Equity
-88.44%
Return on Assets
-64.15%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
2.78
Quick Ratio
2.78

Sales & Book Value

Annual Sales
$310 thousand
Price / Sales
85.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.97 per share
Price / Book
0.95

Miscellaneous

Outstanding Shares
3,100,000
Free Float
3,036,000
Market Cap
$26.35 million
Optionable
Not Optionable
Beta
1.03

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:LMNL) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners